Gregory Allen Hunter

Title: Gregory Allen Hunter and the “Heme Overdrive” Cancer-Treatment Patent.

Introduction

Gregory Allen Hunter is an inventor based in Tampa, Florida, whose patent work focuses on a proposed approach to cancer treatment. His disclosed invention describes a metabolic vulnerability that may be shared across cancers while being absent from normal cells.

Latest Patents

Hunter’s patent, “Heme overdrive rewires pan-cancer cell metabolism,” presents a method for treating cancer by exploiting cancer cells’ dependence on the accumulation of heme intermediates, such as protoporphyrin IX (PPIX). The patent describes how cancer cells rely on genes encoding HMBS, UROS, UROD, and CPOX for survival, while not requiring the same pathway genes to produce early precursors or heme end products.

The proposed treatment induces the accumulation of porphyrin metabolites and then uses a ferroptosis-inducing compound to promote cancer-cell death. The patent presents this approach as a potential therapeutic target across a broad range of cancers, with low or no toxicity to normal cells as a stated objective. Hunter is associated with 1 patent.

Career Highlights

Hunter’s listed institutional affiliation is the University of South Florida. His patent work highlights an effort to translate findings about cancer-cell metabolism into a proposed therapeutic strategy.

Collaborations

Hunter’s listed coworker is Rays Hong Yuan Jiang. Their association reflects collaborative work connected with the patent’s cancer-metabolism research.

Conclusion

Gregory Allen Hunter’s patent proposes targeting cancer cells’ reliance on heme-intermediate accumulation to support a potentially broad cancer-treatment approach.